Salutem Insights

We were delighted to present three posters at ISPOR Europe this year and wanted to share them with you.

First up - The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review.
You can view the full poster here:
📎https://lnkd.in/excwe8gd
#saluteminsights

That’s a wrap on #ISPOREurope 2025!
A great few days connecting, learning & sharing insights in #HEOR and #MarketAccess.
Highlights from the team:
💡 Win – agility with AI
🔍 Sandra – real-world data in EAPs
🧠 Raymond – multi-agentic models

#SalutemInsights #TeamSalutem

Team Salutem are presenting another poster today:
⌛️HPR66 - Early Impact of the Mazars Review on Reimbursement Timelines in Ireland.
🕓 Tuesday 11th November - 16.00 - 19.00
#ISPOREurope #SalutemInsights

A great day of sharing insights, learning from others and meeting colleagues and old friends at ISPOR Europe 2025. Looking forward to tomorrows sessions.
#ISPOREurope #SalutemInisghts

#ISPOREurope2025
Team Salutem presenting today:
🩺 EE702 – Economic Burden of Overweight & Obesity in Europe
💊 HTA52 – Barriers to Reimbursement in Ireland
📊 HPR43 – Managed Access Protocols in Ireland
🕥 10:30–13:30
Full details in images
#HEOR #MarketAccess #SalutemInsights

𝗜𝗦𝗣𝗢𝗥 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟱 - 𝗦𝗮𝗹𝘂𝘁𝗲𝗺 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗣𝗼𝘀𝘁𝗲𝗿𝘀
We’re delighted to share that our team will be presenting multiple posters at ISPOR Europe 2025 in Glasgow this week.

Details on presentation times and locations to follow.

#ISPOREurope#SalutemInsights

📢 Proud to support the PMI Stakeholder Briefing on Nov 20th. Our MD Sandra Redmond will join Dr Lesley Tilson (NCPE) to share insights on reimbursement trends & policy updates. An essential event for the Irish market access community.
Further details: www.linkedin.com/feed/update/...

A look at the Accessus Health Access Briefing Q2.
From Germany to Canada, 14 market access experts (including Salutem Insights ) share HTA updates from Apr–Jun 2025.
📩 Want the full report? Email sandraredmond@saluteminsights.com
🔗 Sign up: bit.ly/AccessusHeal...
#HTA #SalutemInsights

YouTube video by R-HTA consortium R for HTA Workshop 2025 - Raymond Henderson

Dr. Raymond Henderson of Salutem Insights spoke at the R for HTA Workshop on the future of open-source models in health economics.

Watch the talk now:
🎥 bit.ly/RHRforHTAYou...
#HTA #OpenSource #RStats #HealthEconomics #ISPOR

📢 Proud moment! Our Senior HTA Consultant Dr. Raymond Henderson is a co-author on an ISPOR Special Interest Group paper just named an Editor’s Choice for June in Value in Health.

Free to access now 👉 bit.ly/ValueinHealt...

📢Our own Dr. Raymond Henderson will present at the R for HTA Workshop on June 6th at Queen’s University Belfast. He’ll explore open-source health economic models, based on an ISPOR Special Interest Group review.
🕐 12:20 BST
Register here :https://bit.ly/R-HTAWorkshop
#ISPOR #RforHTA #SalutemInsights

The EU HTA journey continues…

Join Sandra Redmond from Salutem Insights tomorrow May 13th as she shares Ireland’s perspective on JCA alongside experts from Belgium, Luxemburg, Norway and Austria

🕓 16:00 | Free to attend
🔗 Register: bit.ly/3Z2iJiD

#EUHTA #HTA #MarketAccess #SalutemInsights

The EU HTA journey continues…

Join Sandra Redmond from Salutem Insights on May 13th as she shares Ireland’s perspective on JCA alongside experts from Belgium, Luxemburg, Norway and Austria

🕓 16:00 | Free to attend
🔗 Register: bit.ly/3Z2iJiD

#EUHTA #HTA #MarketAccess #SalutemInsights

The EU HTA era is here. Join Salutem Insights + EU partners for a 5-part webinar series on JCA across Europe. Starts May 6th @ 16:00.

🗓️ Sandra Redmond speaks on May 13 (Ireland focus).

🔗 Register: www.linkedin.com/feed/update/...
#EUHTA #HTA #MarketAccess #SalutemInsights

🔎 #TacticalTrendsThursday Week 7:
40 drugs reimbursed in 🇮🇪 in 2024.
Avg. timeline: 580 days
⏱️ Faster, yes—but still nearly 2 years to access.
Progress is real, but high-need therapies can’t afford to wait.

#MarketAccess #HTA #Reimbursement #IrishHealthcare #SalutemInsights

🔎 #TacticalTrendsThursday Week 6
The HSE Drugs Group is assessing more meds—but delays are growing.
⏳ Avg. 8 months to first meeting
📈 MAPs rising
🚪 Impacts access & strategy
See infographics for more detail👇

#MarketAccess #HTA #HSEDrugsGroup #SalutemInsights

🔎 Tactical Trends Thursday – Week 5 🔎
Fast movers win! 🏁 1 in 6 HTA submissions in Ireland were made before EMA approval, speeding up reimbursement. Want to gain the advantage in Irish market access? See the data👇
#MarketAccess #HTA #Pharma #SalutemInsights #EUJCA #IrishHealthcare #HealthEconomics

🔎 Tactical Trends Thursday – Week 3 🔎
The Rapid Review plays a key role in Irish reimbursement—how often does it lead to an HTA or price negotiations? ⏳ How quickly are they completed? 📊 What does this mean for 2025 market access? Swipe for insights! 🚀 #SalutemInsights #MarketAccess #HTA #Pharma

🔎 #TacticalTrendsThursday Week 2 🔎
At Salutem Insights, we track every medicine through the full Irish reimbursement process. What’s changing in 2024? 📉 Lower submission volumes, 📊 More complex HTAs, 🎗️ Oncology still leads.
For more insights: bit.ly/SILinkedIn
#SalutemInsights #MarketAccess #HTA

Great day at #IPHAConference2025 and hear of the IPHA
priorities inlcuding faster access to medicines, increasing clinical trials, improving Irish competitiveness and a life sciences strategy. Fantastic to connect with other industry leaders!
#SalutemInsights #Pharma #IPHA

Shane Ryan IPHA President opening the annual Irish Pharmaceutical Healthcare Association (IPHA)conference. IPHA have partnered and collaborated with patient organisations, HCPs and Government to ensure Innovative medicines are available to Irish patients.
#IPHAConference2025 #SalutemInsights

🚨 New Paper Alert! 🚨
Where are we now with Open-Source Models (OSMs) in Health Economics?
Our own Dr. Raymond Henderson & co-authors map the OSM landscape in this ISPOR Special Interest Group report.
📖 Read more: bit.ly/MappingtheLa...

#SalutemInsights #HealthEconomics #ISPOR #DataTransparency

At #SalutemInsights, we track every medicine through the full Irish reimbursement process—from EMA approval to final HSE decision. We're updating our 2024 database - stay tuned for weekly insights on Irish market access starting next Thursday
#MarketAccess #HealthEconomics #HTA

Great discussions at this morning’s PMI Stakeholder Breakfast exploring the impact of US policy changes on the Irish economy & pharma industry.
Thanks to @thepmi.bsky.social for an informative session!
#SalutemInsights #PMI #Pharma #MarketAccess #USPolicy #EconomicImpact

🚨 Latest Insights on the EU Joint Clinical Assessment
The new JCA process is now mandatory for oncology drugs & ATMPs. Our MD, Sandra Redmond, attended the latest SANTE HTA webinar & shared key takeaways.
🔗 Read the full insights here: bit.ly/SalutemInsig...
#SalutemInsights